The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia

Anesthesia and Analgesia

Volumn 89, Issue 2, 1999, Pages 290-295

  Levy, Jerrold H ^a,b   Pitts, Melvin ^a   Thanopoulos, Apostolos ^a   Szlam, Fania ^a   Bastian, Robert ^a   Kim, John ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DIAZEPAM; ETOMIDATE; FENTANYL; HISTAMINE; MIDAZOLAM; NITROUS OXIDE; RAPACURONIUM BROMIDE;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; DRUG EFFECT; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMIC PARAMETERS; HISTAMINE RELEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ANESTHESIA, GENERAL; BLOOD PRESSURE; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HISTAMINE; HISTAMINE RELEASE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 0032787253     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199908000-00005     Document Type: Article

References (17)

1. Wierda JMKH, Broek LVD, Proost JH, et al. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant: a comparison with succinylcholine. Anesth Analg 1993;7:579-84.
2. Wierda JMKH, Beaufort AM, Kleef UW, et al. Preliminary investigations of clinical pharmacology of three short acting non-depolarizing neuromuscular blocking agents Org 9453, Org 9489 and Org 9487. Can J Anaesth 1994;41:213-20.
3. Kahwaji R, Bevan DR, Bikhazi G, et al. Dose-ranging study in younger adult and elderly patients of Org 9487, a new, rapid-onset, short duration muscle relaxant. Anesth Analg 1977;84: 1011-8.
4. Cannon J, Fahey MR, Moss J, Miller RD. Large doses of vecuronium and plasma histamine concentrations. Can J Anaesth 1988;35:350-3.
5. Naguib M, Samarkani AH, Bahamees HS, et al. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995;75:588-92.
6. McCoy EP, Maddinieri VR, Elliot P, et al. Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium. Can J Anaesth 1993;40:703-8.
7. Basta SJ. Release of histamine by nondepolarizing neuromuscular blocking agents. Anesthesiol Rev 1989;16:19-23.
8. Giese JL, Stanley TH. Etomidate: a new intravenous anesthetic induction agent. Pharmacotherapy 1983;3:251-8.
9. Guldager H, Sondergaard I, Jensen FM, et al. Basophil histamine release in asthma patients after in vitro provocation with Althesin and etomidate. Acta Anaesthesiol Scand 1995;29:352-3.
10. Rosow CE, Philbin DM, Keegan CR, Moss J. Hemodynamics and histamine release during induction with sufentanil or fentanyl. Anesthesiology 1984;60:489-91.
11. Laxenaire MC. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia: a French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993;12:91-6.
12. Laxenaire MC, Moneret-Vautrin DA, Widmer S, at al. Substances anesthesiques responsables de chocs anaphylactiques: enquete multicentrique francaise. Ann Fr Anesth Reanim 1990; 9:501-6.
13. Stellato C, Cirillo R, de Paulis A, et al. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 1991;74:1078-86
14. Carpentier F, Nam F, Badaoui R, et al. Les accidents anaphylactoides par le rocuronium: a propos de deux observations. Cah Anesthesiol 1997;45:143-6.
15. Yagi T, Yamamoto Y, Tanaka H, et al. Anaphylactoid reaction to vecuronium. Jpn J Anesthesiol 1993;42:598-601.
16. Yamaguchi K, Huraux C, Szlam F, Levy JH. Vascular effects of ORG 9487 in human mammary arteries, a new short acting muscle relaxant [abstract]. Anesth Analg 1998;86:SCA109.
17. Hou VY, Hirshman CA, Emala CW. Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. Anesthesiology 1998:88:744-50.